Deepali Kumar

ORCID: 0000-0003-1961-0477

Also affiliated with University of Toronto, Toronto General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study”.

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

The Lancet. Gastroenterology & hepatology(2020)10.1016/s2468-1253(20)30081-9

N/A

3.8DataRank · unranked

102 citations

Marcelo Cypel, Deepali Kumar, Harel Dahari, Rafaela Vanin Pinto Ribeiro, Nikki J. Marks +20 more

The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

Transplantation(2025)10.1097/tp.0000000000005374

N/A

0.768DataRank · unranked

166 citations

Deepali Kumar, Oriol Manuel, Sunwen Chou, Randall T. Hayden, Lara Danziger-Isakov +4 more

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study

Clinical Microbiology and Infection(2026)10.1016/j.cmi.2025.09.013

N/A

0.330DataRank · unranked

8 citations

Adrian A. Alexander, Faranak Mavandadnejad, Madeline Kern-Smith, Xiaoqing Dang, Rujun Kang +10 more

Innovation in active and passive immunisation of people who are immunocompromised: a call to action

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00345-7

N/A

0DataRank · unranked

8 citations

Jim Boonyaratanakornkit, Malgorzata Mikulska, Benjamin W. Teh, William O. Hahn, Ghady Haidar +5 more

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad386

N/A

0DataRank · unranked

13 citations

Drew J. Winston, Scott D. Rowley, Kathleen M. Mullane, Pranatharthi Chandrasekar, Parameswaran Hari +14 more

Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients

American Journal of Transplantation(2021)10.1111/ajt.16534

N/A

0DataRank · unranked

24 citations

Arnaud G. L’Huillier, Victor H. Ferreira, Tina Marinelli, Terrance Ku, Matthew Ierullo +6 more

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

Clinical Infectious Diseases(2020)10.1093/cid/ciz1210

N/A

0DataRank · unranked

111 citations

Lynn El Haddad, Drew J. Winston, Scott D. Rowley, Kathleen M Mulane, Pranatharthi Chandrasekar +13 more